Pulmonary Hypertension Roundtable

Advances in Pulmonary Hypertension

¹ 

关键词: Cardiology;    Pulmonology;    Psychosocial Issues;    Lifestyle Issues;    Nursing;    Respiratory Therapy;    Social Work;    WHO Group 1- Pulmonary Arterial Hypertension;    WHO Group 3- Pulmonary hypertension owing to lung disease;    /or hypoxia;    PH Medications;    Pulmonary Function Tests;    Surgical Interventions;    symptoms;    Research;    Palliative Care;    Insurance;    Cardiopulmonary rehabilitation;    Chronic obstructive pulmonary disease (COPD);    Interstital lung disease (ILD);    IV therapy;    Subcutaneous therapy;    Inhaled therapy;    Prostacyclin;    nitric oxide;    Spirometry;    Transplantation;    Preserved ejection fraction;    endothelial dysfunction;    dyspnea;    Functional Class;    patient-reported outcomes;    Drug development;    clinical trial endpoints;    pre-clinical research;    CME;    CEU;    Medicare;    Classification;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

【 摘 要 】

To complement this issue's theme, "Living With Pulmonary Hypertension," a discussion on assisting patients with therapy decisions was led by guest editor Glenna Traiger, RN, MSN, Pulmonary Hypertension CNS, University of California, Los Angeles. The panelists included Karen Frutiger, RN, Clinical Nurse Coordinator, University of Rochester Pulmonary Arterial Hypertension Program, Rochester, NY; Martha Kingman, Nurse Practitioner, University of Texas South- western Medical Center, Dallas; and Abby Poms, RRT, Duke University Pulmonary Vascular Disease Program Manager, Duke University Medical Center, Durham, North Carolina.

【 授权许可】

All Rights reserved